Thyroid dysfunction in newly diagnosed cystic fibrosis patients with pancreatic insufficiency and restitution with enzyme therapy

A. Katelari; Christina Kanaka‐Gantenbein; C Mengreli; George Chrousos; Stavros Doudounakis

doi:10.1016/s1569-1993(09)60326-x

Related publications

Article2015

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma

Antonio Palumbo, Francesca Gay, Federica Cavallo, Francesco Di Raimondo, Alessandra Larocca, Izhar Hardan, Arnon Nagler, Maria Teresa Petrucci, Roman Hájek, Sara Pezzatti, Michel Delforge, Francesca Patriarca, Francesca Donato, Chiara Cerrato, Chiara Nozzoli, Zhinuan Yu, Luana Boccadifuoco, Tommaso Caravita, Giulia Benevolo, Tommasina Guglielmelli, Donatella Vincelli, Christian Jacques, Meletios A Dimopoulos, Giovannino Ciccone, Pellegrino Musto, Paolo Corradini, Michèle Cavo, Mario Boccadoro

Article1993

Combination therapy with interferon‐dexamethasone for newly diagnosed patients with multiple myeloma

Meletios A Dimopoulos, Donna Weber, Kay Delasalle, Raymond Alexanian

Article2020

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

Meletios A Dimopoulos, Andrzej Jakubowiak, Philip L. McCarthy, Robert Z. Orlowski, Michel Attal, Joan Bladé, Hartmut Goldschmidt, Katja Weisel, Karthik Ramasamy, Sonja Zweegman, Andrew Spencer, Jeffrey Huang, Jin Lu, Kazutaka Sunami, Shinsuke Iida, Wee Joo Chng, Sarah A. Holstein, Alberto Rocci, Tomáš Skácel, Richard Labotka, Antonio Palumbo, Kenneth C. Anderson

Article2000

Nasal and Exhaled Nitric Oxide Is Reduced in Adult Patients With Cystic Fibrosis and Does Not Correlate With Cystic Fibrosis Genotype

Stephen R. Thomas, Sergei A. Kharitonov, Sandra Scott, Margaret E. Hodson, Peter J Barnes

Letter2008

Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma

Meletios A Dimopoulos, Efstathios Kastritis